{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T04:08:50Z","timestamp":1794802130045,"version":"4.9.1"},"reference-count":43,"publisher":"Informa UK Limited","issue":"6","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Neurotherapeutics"],"published-print":{"date-parts":[[2024,6,2]]},"DOI":"10.1080\/14737175.2024.2355981","type":"journal-article","created":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T08:59:56Z","timestamp":1716541196000},"page":"607-614","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":13,"title":["The donepezil transdermal system for the treatment of patients with mild, moderate, or severe Alzheimer\u2019s disease: a critical review"],"prefix":"10.1080","volume":"24","author":[{"given":"Austin","family":"Buck","sequence":"first","affiliation":[{"name":"Department of Psychiatry and Behavioral Neurology, Division of Geriatric Psychiatry, Saint Louis University School of Medicine, St. Louis, MO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayvon","family":"Rezaei","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Neurology, Division of Geriatric Psychiatry, Saint Louis University School of Medicine, St. Louis, MO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aman","family":"Quazi","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Neurology, Division of Geriatric Psychiatry, Saint Louis University School of Medicine, St. Louis, MO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Goldmeier","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Neurology, Division of Geriatric Psychiatry, Saint Louis University School of Medicine, St. Louis, MO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bret","family":"Silverglate","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Neurology, Division of Geriatric Psychiatry, Saint Louis University School of Medicine, St. Louis, MO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George T.","family":"Grossberg","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Neurology, Division of Geriatric Psychiatry, Saint Louis University School of Medicine, St. Louis, MO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,5,24]]},"reference":[{"key":"e_1_3_4_3_1","volume-title":"Adams and Victor\u2019s Principles of Neurology, 12e","author":"Ropper A","year":"2023","unstructured":"Ropper A, Samuels M, Klein J, editors., et al. Degenerative diseases of the nervous system. In: Adams and Victor\u2019s Principles of Neurology, 12e. McGraw Hill; 2023."},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.11701"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.6662"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsps.2022.10.004"},{"key":"e_1_3_4_7_1","doi-asserted-by":"crossref","first-page":"107134","DOI":"10.1016\/j.clineuro.2022.107134","article-title":"Efficacy and safety of donepezil for mild cognitive impairment: a systematic review and meta-analysis","volume":"213","author":"Zhang X","year":"2022","unstructured":"Zhang X, Lian S, Zhang Y, et al. Efficacy and safety of donepezil for mild cognitive impairment: a systematic review and meta-analysis. Clin Neurol Neurosurg [Internet]. 2022;213:107134. https:\/\/pubmed.ncbi.nlm.nih.gov\/35078087\/","journal-title":"Clin Neurol Neurosurg [Internet]"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-022-03363-6"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2020.108352"},{"key":"e_1_3_4_10_1","unstructured":"FDA. ADLARITY- donepezil hydrochloride patch [Internet]. dailymed.nlm.nih.gov. Nih. 2022 [cited 2023 Aug 30]. Available from: https:\/\/dailymed.nlm.nih.gov\/dailymed\/fda\/fdaDrugXsl.cfm?setid=1cb44c65-00e8-4b5c-99c2-ad15173115a0&type=display"},{"key":"e_1_3_4_11_1","unstructured":"FDA. DailyMed - RIVASTIGMINE patch [Internet]. dailymed.nlm.nih.gov. 2018 [cited 2024 Apr 8]. Available from: https:\/\/dailymed.nlm.nih.gov\/dailymed\/lookup.cfm?setid=8b671fc9-8cb0-4406-a9ee-7c95086d6200"},{"key":"e_1_3_4_12_1","unstructured":"FDA. DailyMed - ARICEPT- donepezil hydrochloride tablet film coated ARICEPT ODT- donepezil hydrochloride tablet orally disintegrating [Internet]. dailymed.nlm.nih.gov. 2021. Available from: https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=98e451e1-e4d7-4439-a675-c5457ba20975"},{"key":"e_1_3_4_13_1","unstructured":"Drugs.com | Prescription Drug Information Interactions & Side Effects [Internet]. Drugs.com. 2011 [cited 2024 Apr 13]. Available from: https:\/\/www.drugs.com"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.1831"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2021.102549"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.2478\/acph-2019-0016"},{"key":"e_1_3_4_17_1","doi-asserted-by":"crossref","unstructured":"Xu Y Zhao M Cao J et al. Applications and recent advances in transdermal drug delivery systems for the treatment of rheumatoid arthritis. Acta Pharmaceutica Sinica B [Internet]. 2023; Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2211383523001703","DOI":"10.1016\/j.apsb.2023.05.025"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2011.10.031"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-014-0224-6"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cclet.2018.10.037"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2019.02.007"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2019.04.191"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.1c11533"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molliq.2024.124184"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14010205"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2019.03.007"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2016.03.026"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.biomac.2c01155"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2016.06.006"},{"key":"e_1_3_4_30_1","unstructured":"Wang Y Zeng L Song W et al. Influencing factors and drug application of iontophoresis in transdermal drug delivery: an overview of recent progress. Drug Delivery and Translational Research [Internet]. 2021 [cited 2021 Dec 14]. Available from: https:\/\/link.springer.com\/article\/10.1007%2Fs13346-021-00898-6"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119853"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2013.05.029"},{"key":"e_1_3_4_33_1","unstructured":"FDA. FDA evaluating the risk of burns and scars with Zecuity (sumatriptan) migraine patch [Internet]. FDA. 2020 [cited 2024 Feb 16]. Available from: https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-evaluating-risk-burns-and-scars-zecuity-sumatriptan-migraine-patch#:~:text=July%201%2C%202020%2C%20Update%3A"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-220530"},{"key":"e_1_3_4_35_1","unstructured":"FDA. Enforcement Reports [Internet]. www.accessdata.fda.gov. 2018. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/020690s042.pdf"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.4172\/2157-7609.1000129"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S78555"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.3988\/jcn.2022.18.4.428"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-200016030-00005"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/ggi.14566"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-11-57"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2002.tb11294.x"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/gps.1038"},{"issue":"1","key":"e_1_3_4_44_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2125.2004.01848.x","article-title":"The safety and tolerability of donepezil in patients with Alzheimer\u2019s disease","volume":"58","author":"Jackson S","year":"2004","unstructured":"Jackson S, Ham RJ, Wilkinson D. The safety and tolerability of donepezil in patients with Alzheimer\u2019s disease. Brit J Clinical Pharma. 2004 [cited 2019 Mar 11];58(s1):1\u20138. Available from: http:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2125.2004.01848.x\/abstract","journal-title":"Brit J Clinical Pharma"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007990903434914"}],"container-title":["Expert Review of Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737175.2024.2355981","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T09:00:41Z","timestamp":1716541241000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737175.2024.2355981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,24]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6,2]]}},"alternative-id":["10.1080\/14737175.2024.2355981"],"URL":"https:\/\/doi.org\/10.1080\/14737175.2024.2355981","relation":{},"ISSN":["1473-7175","1744-8360"],"issn-type":[{"value":"1473-7175","type":"print"},{"value":"1744-8360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,24]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iern20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iern20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-08-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-13","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}